China may ignore US IP rights on pharmaceuticals in brewing trade war

China may take the "the nuclear option" of ceasing to honour US patents and copyrights, including those of pharmaceutical firms such as Pfizer.
China may take the "the nuclear option" of ceasing to honour US patents and copyrights, including those of pharmaceutical firms such as Pfizer.PHOTO: AFP

BEIJING - In one heart-rending scene of a surprise summer hit here "Dying to Survive", an elderly leukaemia patient begs a detective to end his investigation into the smuggling of illegal generic drugs - which are one-eightieth the cost of the real deal - from India into China.

"Since I became ill, the (legal) drugs have cost me my home and bled my family dry," the patient says. "Now we have an affordable option, yet you insist that they are fake."

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.